Soluble endoglin contributes to the pathogenesis of preeclampsia
Shivalingappa Venkatesha, Mourad Toporsian(University of Toronto), Chun Sing Lam(Harvard University), Jun‐ichi Hanai(Harvard University), Tadanori Mammoto(Beth Israel Deaconess Medical Center), Yeon M. Kim(National Institutes of Health), Yuval Bdolah(Beth Israel Deaconess Medical Center), Kee-Hak Lim(Harvard University), Haitao Yuan(Harvard University), Towia A. Libermann(Harvard University), Isaac E. Stillman(Beth Israel Deaconess Medical Center), Drucilla J. Roberts(Harvard University), Patrìcia A. D'Amore(Massachusetts Eye and Ear Infirmary), Franklin H. Epstein(Harvard University), Frank W. Sellke(Harvard University), Roberto Romero(National Institutes of Health), Vikas P. Sukhatme(Beth Israel Deaconess Medical Center), Michelle Letarte(Heart and Stroke Foundation), S. Ananth Karumanchi(Harvard University)
Cited by 1,841
Abstract
Related Papers
Preeclampsia: An endothelial cell disorder
James Roberts, Robert N. Taylor, Thomas J. Musci et al.|American Journal of Obstetrics and Gynecology|1989|1.9k
VEGF-Trap: A VEGF blocker with potent antitumor effects
Jocelyn Holash, Sam Davis, Nick Papadopoulos et al.|Proceedings of the National Academy of Sciences|2002|1.7k